CIK: 0001056807 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 14, 2025
Total Value ($000): $2,950,708 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 19,751,284 | $1,069,532 | 36.2% | $6.29 | +712.4% | CLASS A ORD | 61559X104 |
| KYMR | KYMERA THERAPEUTICS INC | 5,161,801 | $207,659 | 7.0% | $32.15 | +40.5% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 4,181,179 | $182,885 | 6.2% | $29.44 | +71.4% | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 1,388,064 | $117,444 | 4.0% | $79.32 | +15.9% | COM | 05464T104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 2,796,513 | $115,636 | 3.9% | $27.38 | +52.2% | COM | 604749101 |
| XOMA | XOMA ROYALTY CORPORATION | 3,633,743 | $95,495 | 3.2% | $15.57 | +87.7% | COM NEW | 98419J206 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 1,900,015 | $73,341 | 2.5% | $18.37 | +137.4% | COM | 74366E102 |
| GHRS | GH RESEARCH PLC | 10,400,158 | $72,801 | 2.5% | $18.98 | -57.6% | ORDINARY SHARES | G3855L106 |
| CGEM | CULLINAN THERAPEUTICS INC | 5,750,683 | $70,043 | 2.4% | $20.31 | -29.2% | COM | 230031106 |
| ZYME | ZYMEWORKS INC | 4,308,935 | $63,083 | 2.1% | $7.03 | +99.0% | COM | 98985Y108 |
| SEPN | SEPTERNA INC | 2,452,024 | $56,151 | 1.9% | $23.65 | 0.0% | COM | 81734D104 |
| TYRA | TYRA BIOSCIENCES INC | 3,944,194 | $54,824 | 1.9% | $16.23 | +11.8% | COM | 90240B106 |
| ACIU | AC IMMUNE SA | 19,522,436 | $52,711 | 1.8% | $4.52 | -30.9% | SHS | H00263105 |
| XNCR | XENCOR INC | 2,288,760 | $52,596 | 1.8% | $21.42 | +7.3% | COM | 98401F105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,771,417 | $48,041 | 1.6% | $34.21 | — | SPONSORED ADS | 86366E106 |
| CELC | CELCUITY INC | 3,466,000 | $45,370 | 1.5% | $16.73 | -15.7% | COM | 15102K100 |
| GLPG | GALAPAGOS NV | 1,569,422 | $43,159 | 1.5% | $38.91 | — | SPON ADR | 36315X101 |
| — | VERVE THERAPEUTICS INC | 6,904,050 | $38,939 | 1.3% | $8.34 | — | COM | 92539P101 |
| ANNX | ANNEXON INC | 7,000,000 | $35,910 | 1.2% | $2.47 | +148.6% | COM | 03589W102 |
| AGIO | AGIOS PHARMACEUTICALS INC | 1,073,755 | $35,284 | 1.2% | $36.09 | +30.2% | COM | 00847X104 |
| — | 89BIO INC | 4,333,885 | $33,891 | 1.1% | $10.69 | — | COM | 282559103 |
| OLMA | OLEMA PHARMACEUTICALS INC | 5,715,893 | $33,324 | 1.1% | $37.66 | -73.5% | COM | 68062P106 |
| — | CIDARA THERAPEUTICS INC | 1,092,796 | $29,374 | 1.0% | $16.88 | — | COM NEW | 171757206 |
| ELDN | ELEDON PHARMACEUTICALS INC | 6,293,282 | $25,928 | 0.9% | $4.95 | -20.4% | COM | 28617K101 |
| FHTX | FOGHORN THERAPEUTICS INC | 5,302,000 | $25,025 | 0.8% | $5.96 | +22.3% | COM | 344174107 |
| — | THIRD HARMONIC BIO INC | 2,372,933 | $24,417 | 0.8% | $16.07 | — | COM | 88427A107 |
| KURA | KURA ONCOLOGY INC | 2,567,469 | $22,363 | 0.8% | $13.94 | +3.2% | COM | 50127T109 |
| — | ALLAKOS INC | 16,552,417 | $20,028 | 0.7% | $3.39 | — | COM | 01671P100 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 2,764,471 | $19,185 | 0.7% | $7.50 | 0.0% | COM | 61225M102 |
| — | ITEOS THERAPEUTICS INC | 2,325,000 | $17,856 | 0.6% | $7.68 | — | COM | 46565G104 |
| — | ESSA PHARMA INC | 8,748,629 | $15,660 | 0.5% | $3.65 | — | COM NEW | 29668H708 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 2,670,642 | $14,875 | 0.5% | $20.48 | -61.7% | COM | 35104E100 |
| — | RAPT THERAPEUTICS INC | 9,237,556 | $14,595 | 0.5% | $1.58 | — | COM | 75382E109 |
| ENGN | ENGENE HOLDINGS INC | 2,106,037 | $14,005 | 0.5% | $10.40 | -25.3% | COM | 29286M105 |
| — | REPARE THERAPEUTICS INC | 10,333,600 | $13,537 | 0.5% | $19.56 | — | COM | 760273102 |
| FBRX | FORTE BIOSCIENCES INC | 594,282 | $13,496 | 0.5% | $11.57 | +2.8% | COM NEW | 34962G208 |
| VSTM | VERASTEM INC | 2,100,468 | $10,859 | 0.4% | $6.35 | -38.0% | COM NEW | 92337C203 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $9,088 | 0.3% | $2.68 | +69.2% | COM | 89854M101 |
| IMUX | IMMUNIC INC | 8,902,972 | $8,903 | 0.3% | $1.30 | -3.0% | COM | 4525EP101 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 696,555 | $8,359 | 0.3% | $15.71 | 0.0% | COM | 697947109 |
| AVTX | AVALO THERAPEUTICS INC | 1,036,679 | $7,703 | 0.3% | $10.33 | +3.5% | COM NEW | 05338F306 |
| — | IKENA ONCOLOGY INC | 4,006,564 | $6,571 | 0.2% | $12.00 | — | COM | 45175G108 |
| MOLN | MOLECULAR PARTNERS AG | 1,353,968 | $6,458 | 0.2% | $9.66 | — | ADS | 60853G106 |
| CTMX | CYTOMX THERAPEUTICS INC | 5,228,461 | $5,385 | 0.2% | $5.34 | -79.9% | COM | 23284F105 |
| OVID | OVID THERAPEUTICS INC | 3,853,818 | $3,598 | 0.1% | $4.24 | -73.6% | COM | 690469101 |
| SABS | SAB BIOTHERAPEUTICS INC | 917,826 | $3,506 | 0.1% | $5.51 | -40.3% | COM NEW | 78397T202 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $3,083 | 0.1% | $9.10 | — | COM | 92673K108 |
| — | GLYCOMIMETICS INC | 9,544,262 | $2,377 | 0.1% | $4.18 | — | COM | 38000Q102 |
| TENX | TENAX THERAPEUTICS INC | 339,549 | $2,102 | 0.1% | $3.62 | +34.0% | COM NEW | 88032L605 |
| — | ELEVATION ONCOLOGY INC | 2,966,836 | $1,669 | 0.1% | $8.04 | — | COM | 28623U101 |
| IVA | INVENTIVA SA | 686,040 | $1,475 | 0.0% | $13.70 | — | ADS | 46124U107 |
| ENGNW | ENGENE HOLDINGS INC | 945,402 | $804 | 0.0% | $0.85 | — | *W EXP 10/31/202 | 29286M113 |
| — | NLS PHARMACEUTICS LTD | 143,676 | $303 | 0.0% | $5.07 | — | COM NEW | H57830137 |